RNAi Roundup: Off-Target Gene Silencing Issues; Why Exelixis Chose Dharmacon to Provide 600 siRNAs; and Sequitur s Stealth RNAi | GenomeWeb

NEW YORK, June 13 - One would think the recent evidence that short interfering RNA has off-target gene silencing effects might put a damper on the burgeoning business of siRNA companies.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.